Given that not all individual cancer cells in human tumours are unresponsive to IFNγ, we used a B16-OVA WT and IFNγRKO admix model whereby tumour cells are tagged in ZsGreen or mCherry, or vice versa, and mixed in equal proportions prior to engraftment (Fig. 2E). The gene discussed is IFNG; the disease is cancer.